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A B S T R A C T
Introduction:: There is a paucity of research into the psychiatric problems associated with early stage HIV
clinical disease in sub-Saharan Africa.
Methods: A cross sectional study was undertaken among 899 adult ART naïve persons in early stage HIV
clinical disease (participants with CD4≥250 and who were at WHO clinical Stage I or II) attending a semi-urban
and a rural clinic in Uganda.
Results: The prevalence of major depressive disorder in this study was 14.0% [95% CI 11.7–6.3%] while that of
‘moderate to high risk for suicidality’ was 2.8% [95% CI 1.7%; 3.9%]. Multivariable analyses found that factors
in the socio-demographic, vulnerability/protective and stress (only for major depressive disorder) domains were
signiﬁcantly associated with both major depressive disorder and ‘moderate to high risk for suicidality’. Major
depressive disorder but not ‘moderate to high risk for suicidality’ was signiﬁcantly associated with impaired
psychosocial functioning, greater utilisation of health services and non-adherence to septrin/dasone. Neither
major depressive disorder nor ‘moderate to high risk for suicidality’ was associated with CD4 counts, risky
sexual behaviour nor with non-utilisation of condoms.
Limitations: The bidirectional nature of some of the relationships between the investigated psychiatric
problems, risk factors and outcomes in this cross sectional study makes it diﬃcult to elucidate the actual
direction of causality.
Conclusion: Early stage HIV clinical disease is associated with considerable major depressive disorder and
‘moderate to high risk for suicidality’. Therefore there is a need to integrate mental health into HIV
interventions that target early stage HIV disease.
1. Background
Most of the research into psychiatric problems in HIV/AIDS in
Africa has been undertaken during late stage HIV clinical disease with a
dearth of research during the earlier stages of HIV infection. This is
despite the fact that the pattern of psychiatric problems and its
associated risk factors varies along the HIV disease course (Musisi
and Kinyanda, 2009; Fernandez and Ruiz, 2006). Additionally, from
studies undertaken in the West among newly diagnosed persons living
with HIV (PLWH), psychiatric problems such as major depressive
disorder have been reported to be highly prevalent and to be associated
with the negative clinical and behavioural outcomes of poor linkage to
HIV care, more likely to report barriers to appointment adherence and
high risk sexual behaviour (Bhatia et al., 2012; Metsch et al., 2008).
http://dx.doi.org/10.1016/j.jad.2017.01.033
Received 13 April 2016; Received in revised form 31 August 2016; Accepted 23 January 2017
⁎ Corresponding author at: Mental Health Project, MRC/UVRI Uganda Research Unit on AIDS, P.O. Box 49, Entebbe, Uganda.
E-mail addresses: Eugene.Kinyanda@mrcuganda.org (E. Kinyanda), drnoeline@yahoo.com (N. Nakasujja), Jonathan.Levin@mrcuganda.org (J. Levin),
htbrabwa@yahoo.com (H. Birabwa), Heiner.Grosskurth@lshtm.ac.uk (H. Grosskurth), SSEEDAT@sun.ac.za (S. Seedat), vikram.patel@lshtm.ac.uk (V. Patel).
Journal of Affective Disorders 212 (2017) 117–127
Available online 23 January 2017
0165-0327/ © 2017 Elsevier B.V. All rights reserved.
MARK
However, two recent policy changes in HIV prevention and treatment
including in sub-Saharan Africa are going to increasingly bring PLWH
into contact with HIV care services while they are still in early stage
disease. These policy changes include ﬁrstly, that many countries in
sub-Saharan Africa are in addition to providing Voluntary HIV Testing
(VCT) also embracing Routine HIV Testing (RHT) in all clinical
encounters and in home based settings (Ministry of Health Uganda,
2010; National Department of Health, Republic of South Africa, 2009).
Secondly, the WHO in 2015 recommended that all people living with
HIV should be oﬀered antiretroviral therapy irrespective of their CD4
counts (World Health Organisation, 2015). Therefore in the sub-
Saharan African context, there is a need to better understand the
pattern and magnitude of the psychiatric problems in early stage HIV
disease, their risk factors and their impact on clinical and behavioural
outcomes. In response to this need, the Mental Health Project at the
MRC/UVRI Uganda Research Unit on AIDS undertook a study to
investigate psychiatric problems among HIV positive patients in early
stage HIV clinical disease. We looked at the burden of two of the
commonest psychiatric problems (major depressive disorder and
suicidality) reported in this setting (Kinyanda et al., 2011a, 2012a)
and assessed their association with a broad range of explanatory risk
factors and potential negative health consequences. The results of this
study are presented in this paper.
2. Methods
2.1. Study design and Site
This was a cross sectional study undertaken at two specialised HIV
clinics run by the AIDS Support Organisation (TASO) at Entebbe
(semi-urban) and Masaka (predominantly rural) (TASO Services and
Programme, 2014). The MRC/UVRI Uganda Research Unit (the host
research institution) has an established research collaboration with
these two study clinics. The TASO Entebbe clinic has 7000 active
clients of whom about 3000 are ART naïve while the TASO Masaka
clinic has 6000 active clients of whom about 2500 are not on ART. The
study was conceived as a multisite study in which the analysis would
combine the data over the two sites.
2.2. Sampling procedure
A sample size of 1100 respondents was estimated to be suﬃcient to
determine the prevalence of the investigated psychiatric problems
(major depressive disorder (MDD) and ‘moderate to high risk for
suicidality’ (MHS) with a precision of at least 2%, assuming that the
true prevalence was in the order of 11%. To arrive at this estimated
prevalence, we used rates of psychiatric problems from a previous
study undertaken by this research group in the semi-urban district of
Entebbe (one of the study sites of this project) where a rate of 8.3% for
MDD (Kinyanda et al., 2011a) and 7.8% for MHS (Kinyanda et al.,
2012a) were obtained. These rates were then adjusted to 11% for each
psychiatric problem to take care of the anticipated higher prevalence at
the rural site. To obtain this sample, a sub-register of all active clients
who were not on ART was created at each of the study sites. From each
sub-register, a random sample of 550 ART naïve patients was selected
using a table of random numbers to give a combined study sample of
1100. We did not collect information to estimate participation rate.
Inclusion Criteria: i) A person who was living with HIV (PLWH)
who was ART naïve and registered with the outpatient clinic at either
TASO Entebbe and TASO Masaka clinics; ii) was an adult at the time of
enrolment (at least 18 years old); iii) was conversant with Luganda, the
language into which the research protocols were translated; iv) gave
informed consent after adequate explanation of the study objectives,
procedures and expected beneﬁts.
Exclusion Criteria: i) was too sick (those patients who come to
the HIV clinics with severe physical health problems and are unwell
and need emergency assessment and hospitalisation)] and ii) unable to
understand the study instruments.
2.3. Data collection tools
The data collection tools consisted of structured and standardised
locally translated psychosocial assessment tools most of which have
previously been used among PLWH in the Ugandan setting by this
study group (Kinyanda et al., 2011a, 2012a). The data collection tool
was administered by trained psychiatric nurses who were supervised by
a psychiatrist (E.K.). The psychosocial assessment tools being em-
ployed for the ﬁrst time in the Ugandan HIV setting were taken
through a process of local adaptation. This involved a process of
forward and back translation by two teams of mental health profes-
sionals conversant with both English and the local language of
translation (Luganda) working independent of each other. At a con-
sensus meeting where both these teams were represented the ﬁnal back
translated English version was then compared to the initial English
version. On those items where there was wide variation in the two
versions, a consensus position was arrived at through discussion. The
internal consistency of each of all the tools being used for the ﬁrst time
was determined by assessing their Cronbach's alpha and only those
tools which had Cronbach's alpha of at least 0.4 were included in
subsequent analysis for this study.
The data collection tools for this study were compiled together into
the following groups (see conceptual framework in Fig. 1): socio-
demographic factors (Group 1); vulnerability/protective factors (Group
2 A); stressors (Group 2B); psychiatric outcomes (Group C); and
negative clinical and behavioural outcomes (Group 3). The composition
of these groupings was underpinned by the stress-vulnerability hy-
potheses of depression and suicidality (Monroe and Simons, 1991;
Mann et al., 1999; Wasserman, 2001) which state that depression and
suicidality will develop only when stress factors act on an underlying
vulnerability (see Fig. 1). Psychiatric problems were assessed using the
M.I.N.I. neuropsychiatric interview (MINI Plus) which is a modular
DSM IV based structured interview (Sheehan et al. (1998)). The two
psychiatric problems that were assessed for this study were: current
major depressive disorder (MDD) as deﬁned by DSM IV in the MINI
Plus module; and ‘moderate to high risk for suicidality’ (MHS) as
deﬁned in the suicidality module of the MINI Plus to be a score of nine
and above on the suicidality items of the MINI Plus module on
suicidality, we broadened this deﬁnition to also include those who
had attempted suicide in the last month despite not attaining the score
threshold of nine on the suicidality module of the MINI Plus’. The other
data collection tools are described in Appendix A.
2.4. Statistical analysis
In this study there were two sets of dependent variables, namely the
psychiatric problems variables -major depressive disorder(MDD) and
moderate to high risk for suicidality (MHS) and the clinical and
behavioural outcomes variables (see Appendix A). For the psychiatric
problems outcomes, the prevalence of MDD and MHS were estimated
together with exact binomial 95% conﬁdence limits. To undertake the
analysis for this study, the approach recommended by Victoria et al.
(1997) for multivariable analysis was used. Firstly, the association of
socio-demographic factors was investigated through the use of a
backward elimination logistic regression model, choosing the candidate
variables based on prior knowledge and plausibility, and using a liberal
P-value (15%) for removal, in order to ensure that all variables that
could have a possible confounding eﬀect on the ultimate risk factors
were included, as recommended by Royston et al. (1999).
According to the stress-vulnerability hypotheses for depression and
suicidality (Monroe and Simons, 1991; Mann et al., 1999; Wasserman,
2001), the socio-demographic variables (Group 1 variables) act in-
dependently on two groups of proximal factors, namely a set of
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vulnerability /protective variables (Group 2A variables) and a set of
stressor variables (Group 2B variables). Thus two second stage models
were ﬁtted, the ﬁrst involving the selected Group 1 and Group 2A
variables, while the second involved the selected Group 1 and Group 2B
variables. In each case variables were removed from the logistic
regression model using a backward elimination algorithm with a
stricter 10% nominal P-value for removal, always keeping the selected
Group 1 variables in the model. The vulnerability/protective factors
(Group 2A) and stressor factors (Group 2B) selected in this way were
then kept in the ﬁnal logistic regression model, together with all
selected Group 1 variables. As pointed out by Victoria et al. (1997), part
of the eﬀect of the socio-demographic variables will be mediated
through the vulnerability / protective variables or through the stress
variables, so in the case of MDD, none of the selected socio-demo-
graphic variables were removed from the ﬁnal model. In the case of
MHS, variables that were no longer signiﬁcant at the 10% level were
removed and employment status was dichotomised as employed vs.
unemployed, since only 25 participants had moderate to high suicid-
ality and an informal rule of thumb suggests about 5 cases for each
variable included in the ﬁnal model. For all continuous explanatory
variables the possibility that the underlying relationship between the
outcome and the variable is not linear was investigated by ﬁtting
fractional polynomials of degree 1 to ﬁnd the best form of the
relationship between the outcome and the explanatory variable. This
was done by choosing the power transformation xp with the power p
chosen from the candidates {−2, −1, −0.5, 0, 0.5, 1, 2, 3} where x0
denotes log(x). The non-linear function was preferred only if a test of
p=1 against the best ﬁtting model with p‡1 was statistically signiﬁcant
at the 5% level. The test was performed by comparing the diﬀerence in
model deviances with a χ2 distribution on 1 d.f. (Royston et al., 1999).
For the descriptive tables only, the continuous explanatory variables
were categorised in order to see any apparent tends in the outcome
variables. Interactions between those exposures found to be signiﬁcant
predictors of MDD or MHS and study site were investigated in order to
justify combining the data across the two study sites.
The negative behavioural outcome variables (Group 3) were regarded
as either ordinal (days of normal activity disrupted in the last month,
number of times a Health Unit was visited in the last month, number of
days admitted to Hospital in the last month and the high risk sexual
behaviour index) or binary (whether Septrin / Dapsone treatment had
been missed in the previous three days, whether the participant had
engaged in any high risk sexual behaviour and whether those partici-
pants who had engaged in high risk behaviour had done so without using
a condom). In the case of the ordinal outcomes, ordinal logistic
regression models were ﬁtted to investigate whether the outcome was
associated with MDD or MHS, while for the binary outcomes logistic
regression models were ﬁtted. In each case, on the basis of prior
knowledge, it was decided to adjust for study site, age, sex, educational
Fig. 1. Conceptual framework based on the stress vulnerability models for major depressive disorder and suicidality.
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level and most recent CD4 count (in the past 6 months). Fractional
polynomials of degrees 1 and 2 were explored to investigate potential
nonlinearity in the response to age and CD4 count (Royston et al., 1999).
2.5. Ethical considerations
The study obtained ethical approval from the Uganda Virus
Research Institute's Science and Ethics Committee and the Uganda
National Council of Science and Technology. Study participants were
invited to consent after being provided with adequate information
about the study. Respondents found to have signiﬁcant psychiatric
problems were referred to the psychiatric departments at Entebbe
district hospital (at the semi-urban site) and Masaka regional referral
hospital (rural site) for further assessment and management.
3. Results
3.1. Prevalence of major depressive disorder (MDD) and ‘moderate to
high risk for suicidality’ (MHS)
Out of the 1100 study participants enrolled in this study, 201
(18.3%) were excluded from this analysis because they either had a
CD4 count of less than 250 or were at WHO stage III or IV (were in late
stage HIV disease). Out of 899 participants included in the analysis,
126 had major depressive disorder (MDD), a prevalence of 14.0% (95%
CI 11.7–16.3%). The prevalence was higher in Masaka (rural site) than
in Entebbe (urban site). In Masaka 92/473 had MDD, giving a
prevalence of 19.5% (95% CI 15.9–23.0%), while in Entebbe 34/426
had MDD giving a prevalence of 8.0% (95% CI 5.4–10.6%).
Overall 25 participants had ‘moderate to high risk for suicidality’
(MHS), a prevalence of 2.8% (95% CI 1.7–3.9%). The prevalence of
suicidality was slightly higher in Masaka ( 17/473) giving a prevalence
of 3.6% [95% CI ( 2.1% −5.7%)] than in Entebbe ( 8/424) giving a
prevalence of 1.9% [95% CI ( 0.8–3.7%)]. Of the 25 participants who
had MHS, 20 also had comorbid MDD, thus 106 ( 11.8%) had MDD
only, 5 ( 0.6%) had MHS only and 20 ( 2.2%) a comorbidity of both
MDD and MHS.
3.2. Factors associated with MDD and MHS
Tables 1, 2 give the prevalence of MDD and MHS broken down by
the levels of potential explanatory factors; for the purpose of these
descriptive tables only, the continuous explanatory variables have been
categorized.
3.2.1. Factors associated with MDD
From Table 1, at bivariate analysis, the following baseline factors
were associated with MDD: study site (higher in the rural site
Table 1
Prevalence of both major depressive disorder (MDD) and moderate to high risk of suicidality (MHS) by socio-demographic factors.
Variable Level Major depressive disorder
(n=126) n (%)
Test Statistic
(p-value)
Moderate to high risk
suicidality (n=25) n (%)
Test Statistic
(p-value)
Socio-demographic
factors
Study Site Entebbe (n=424) 34 (8.0%) Χ1
2 = 24.46 8 (1.9%) Χ1
2 = 2.44
Masaka (n=473) 92 (19.4%) (P < 0.001) 17 (3.6%) (P=0.12)
Sex Male (n=194) 16 (8.2%) Χ1
2 = 6.83 4 (2.1%) Χ1
2 = 0.47
Female (n=705) 110 (15.6%) (P=0.009) 21 (3.0%) (P=0.49)
Educational Level No education (n=99) 20 (20.2%) Χ2
2 = 4.54 6 (6.1%) Χ2
2 = 5.01
Primary (n=559) 79 (14.1%) (P=0.10) 15 (2.7%) (P=0.08)
Secondary / Further
(n=238)
27 (11.3%) 4 (1.7%)
Missing (n=3) 0 0
Marital Status Currently Married (n=466) 53 (11.4%) Χ3
2 = 6.00 7 (1.5%) Χ3
2 =7.40
Widowed (n=136) 24 (14.1%) (P=0.11) 6 (4.4%) (P=0.06)
Separated / Divorced
(n=210)
36 (17.1%) 7 (3.3%)
Single (n=85) 13 (15.3%) 5 (5.9%)
Missing (n=2) 0 0
Religion Catholic (n=482) 71 (14.7%) Χ5
2 = 2.85 11 (2.3%) Χ5
2 = 11.21
Protestant (n=192) 29 (15.1%) (P=0.72) 5 (2.6%) (P=0.05)
Muslim (n=133) 18 (13.5%) 6 (4.5%)
SDA (n=12) 1 (8.3%) 1 (8.3%)
Born Again (n=76) 7 (9.2%) 1 (1.3%)
Other (n=4) 0 1 (25%)
Employment Status Farmer / Fisherman
(n=262)
38 (14.5%) Χ4
2 = 8.67 6 (2.3%) Χ4
2 = 17.48
Professional / Clerical
(n=33)
0 (P=0.07) 1 (3.0%) (P=0.002)
Trader / Artisan /
Transport (n=331)
44 (13.3%) 4 (1.2%)
Unemployed / Retired
(n=117)
23 (19.7%) 10 (8.6%)
Student / Other (n=147) 20 (13.6%) 4 (2.7%)
Missing (n=9) 1 (11.1%) 0
Age (years) 18 – 29 (n=278) 38 (13.7%) Χ4
2 = 6.99 9 (3.2%) Χ4
2 = 7.07
30 – 34 (n=205) 32 (15.6%) (P=0.14) 10 (4.9%) (P=0.13)
35 – 39 (n=162) 22 (13.6%) 1 (0.6%)
40 – 49 (n=185) 31 (16.8%) 4 (2.2%)
> = 50 (n=69) 3 (4.4%) 1 (1.4%)
Socio-economic status index
(SES)
< =12 (n=210) 37 (17.6%) Χ3
2 = 7.15 11 (5.2%) Χ3
2 = 7.91
13 – 15 (n=316) 50 (15.8%) (P=0.07) 8 (2.5%) (P=0.05)
16 – 19 (n=274) 30 (11.0%) 6 (2.2%)
> =20 (n=98) 9 (9.2%) 0
Missing (n=1) 0 0
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compared to the urban site); sex (higher among females compared to
males); and employment status (highest among the unemployed/
retired group compared to the other employment categories). From
Table 2, at bivariate analysis, the following psychosocial factors were
associated with MDD: increasing childhood trauma scores, increasing
negative coping style scores, food insecurity, increasing negative life
Table 2:
Prevalence of both major depressive disorder (MDD) and moderate to high risk of suicidality (MHS) by clinical and psychosocial risk factors.
Factor Level (N=899) Major depressive disorder
(n=126) n (%)
Test Statistic
(p-value)
Moderate to high risk
suicidality (n=25) n (%)
Test Statistic
(p-value)
Clinical Factors
Family history of psychiatric
illness
Yes (n=246) 42 (17.1%) Χ1
2 = 2.80 8 (3.2%) Χ1
2 = 0.24
No (n=644) 82 (12.7%) (P=0.09) 17 (2.6%) (P=0.62)
Missing (n=9) 2 (22.2%) 0
WHO stage I (n=471) 72 (15.3%) Χ1
2 = 1.33 15 (3.2%) Χ1
2 = 0.60
II (n=428) 54 (12.6%) (P=0.25) 10 (2.3%) (P=0.44)
CD4 counts (cells / µl) 250 – 349 (n=103) 17 (16.5%) Χ3
2 = 1.05 5 (4.8%) Χ3
2 = 2.77
350 – 499 (n=325) 44 (13.5%) 8 (2.5%) (P=0.43)
500 – 749 (n=300) 39 (13.0%) (P=0.79) 6 (2.0%)
> =750 (n=171) 26 (15.2%) 6 (3.5%)
Weight (kg) < 50 (n=91) 19 (20.9%) Χ3
2 = 6.85 3 (3.3%) Χ3
2 = 2.24
50 – 59 (n=306) 43 (14.0%) (P=0.08) 11 (3.6%) (P=0.52)
60 – 69 (n=326) 44 (13.5%) 6 (1.8%)
> =70 (n=146) 13 (8.9%) 3 (2.0%)
Missing (n=30) 7 (23.3%) 2 (6.7%)
When did you know your HIV
status?
< 3 months (n=75) 16 (21.3%) Χ3
2 = 4.2 4 (5.3%) Χ3
2 = 6.53
3 – 6 months
(n=78)
8 (10.3%) (P=0.24) 2 (2.6%) (P=0.088)
6 – 12 months
(n=79)
11 (13.9%) 5 (6.3%)
> 12 months
(n=661)
91 (13.8%) 14 (2.1%)
Missing (n=6) 0 (0%) 0 (0%)
Psychological Factors
Childhood trauma score < =83 (n=441) 46 (10.4%) Χ3
2 = 17.12 9 (2.0%) Χ3
2 = 5.99
84 – 89 (n=245) 37 (15.1%) (P=0.001) 7 (2.9%) (P=0.11)
90 – 99 (n=135) 21 (15.6%) 3 (2.2%)
> =100 (n=71) 20 (28.2%) 5 (7.0%)
Missing (n=7) 2 (28.6%) 1 (14.3%)
Stigma Score 10 – 19 (n=166) 9 (5.4%) Χ3
2 = 33.42 3 (1.8%) Χ3
2 = 19.92
20 – 24 (n=400) 45 (11.2%) (P < 0.001) 3 (0.8%) (P < 0.001)
25 – 29 (n=240) 46 (19.2%) 11 (4.6%)
> =30 (n=83) 24 (28.9%) 7 (8.4%)
Missing (n=10) 2 (20%) 1 (10%)
Coping Scale Score < =49 (n=202) 13 (6.4%) Χ4
2 = 32.41 2 (1.0%) Χ4
2 = 12.39
50 – 54 (n=10) 17 (10.0%) (P < 0.001) 1 (0.6%) (P=0.02)
55 – 59 (n=174) 22 (12.6%) 8 (4.6%)
60 – 69 (n=272) 50 (18.4%) 8 (2.9%)
> =70 (n=73) 22 (30.1%) 5 (6.8%)
Missing (n=8) 2 (25%) 1 (12.5%)
Resilience Score < =49 (n=149) 52 (34.9%) Χ4
2 = 74.83 15 (10.1%) Χ4
2 = 37.22
50 – 59 (n=138) 23 (16.7%) (P < 0.001) 1 (0.7%) (P < 0.001)
60 – 69 (n=218) 25 (11.5%) 4 (1.8%)
70 – 79 (n=199) 11 (5.5%) 2 (1.0%)
> =80 (n=181) 13 (7.2%) 2 (1.1%)
Missing (n=14) 2 (14.3%) 1 (7.1%)
Social Support Score < =27 (n=101) 23 (22.8%) Χ2
2 = 13.78 8 (7.9%) Χ2
2 = 16.16
28 – 37 (n=323) 54 (16.7%) (P=0.001) 12 (3.7%) (P < 0.001)
38 – 48 (n=475) 49 (10.3%) 5 (1.0%)
Depression (excluding suicidality
items)
No (n=791) – 8 (1.0%) Χ1
2 = 76.26
Yes (n=108) 17 (15.7%) (P < 0.001)
Probable Dementia (IHDS < 10) No (n=477) 56 (11.7%) Χ1
2 =4.49 9 (1.9%) Χ1
2 =3.05
Yes (n=420) 70 (16.7%) (P=0.03) 16 (3.8%) (P=0.08)
Missing (n=2) 0 0
Social Factors
Negative Life Events 0 (n=113) 5 (4.4%) Χ3
2 =46.76 1 (0.9%) Χ3
2 =10.54
1 – 3 (n=318) 33 (10.3%) (P < 0.001) 6 (1.9%) (P=0.02)
4 – 9 (n=354) 51 (14.4%) 10 (2.8%)
> =10 (n=111) 37 (33.3%) 8 (7.2%)
Stress Score 0 (n=134) 5 (3.7%) Χ3
2 = 42.09 1 (0.8%) Χ3
2 = 9.21
1 – 4 (n=318) 33 (10.4%) (P < 0.001) 7 (2.2%) (P=0.03)
5 – 9 (n=259) 37 (14.3%) 6 (2.3%)
> =10 (n=188) 51 (27.1%) 11 (5.8%)
Food Security Have enough (n=729) 86 (11.8%) Χ1
2 = 15.40 14 (1.9%) Χ1
2 = 11.03
Not enough (n=166) 39 (23.5%) (P < 0.001) 11 (6.6%) (P=0.001)
Missing (n=4) 1 (25.0%) 0
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events scores, increasing stress scores, increasing HIV stigma scores,
higher HIV dementia scores, decreasing resilience scores and decreas-
ing social support scores.
Table 3 shows the results of ﬁtting multiple logistic regression
models guided by the stress-vulnerability hypothesis of depression
(Monroe and Simons, 1991) to ﬁnd factors associated with MDD. The
group 1 variables chosen were study site, age and sex. The group 2A
variables chosen were stigma score, childhood trauma score, negative
coping score and resilience score; the use of fractional polynomials
showed that the eﬀect of resilience score was non-linear. The only
group 2B variable chosen was the negative life experiences score. This
process led to the ﬁnal model shown in Table 3. The odds of MDD were
more than three times higher in Masaka than in Entebbe and were
higher for females. The odds of MDD increased with increasing stigma
score, increasing childhood trauma score, increasing negative coping
score and increasing negative life experiences score. The odds of
depression decreased with increasing resilience score, but the eﬀect
was nonlinear and became weaker with increasing resilience, with the
eﬀect being most marked at resilience scores below 50. Note that
Victoria et al. (1997) point out that group 1 variables should remain in
the model even if the eﬀect is no longer statistically signiﬁcant (such as
the eﬀect of age here), as the eﬀect of such variables is mediated
through other variables. Interactions were investigated between the
exposures included in the ﬁnal model for MDD and study site. None of
the interactions were found to be signiﬁcance at the 5% level.
3.2.2. Factors associated with MHS
From Tables 1, 2, at bivariate analysis, the following baseline
factors were associated with MHS: employment status (highest among
the unemployed/retired group compared to the other employment
categories); and the psychosocial factors of increasing HIV stigma
scores, increasing negative coping style scores, decreasing resilience
scores and decreasing social support scores.
Table 4 shows the results of ﬁtting multiple logistic regression
models guided by the conceptual framework, to ﬁnd factors associated
with MHS. The group 1 variables chosen were study site, SES index and
employment status; due to the small number of cases there was a need
to restrict the number of terms in the model, thus employment status
was recoded as unemployed / retired vs. others. The group 2A variables
chosen were current depression (on the modiﬁed depression scale), felt
stigma score and resilience score; the use of fractional polynomials
showed that the eﬀect of resilience score was nonlinear. No group 2B
variable was chosen. This process led to the ﬁnal model shown in
Table 4. The odds of MHS were lower in Masaka than in Entebbe. The
odds of MHS decreased with increasing SES score. The odds of MHS
increased with increasing felt stigma score and were over seven times
as high for participants with current depression (on the modiﬁed
scale). The odds of MHS decreased non-linearly with increasing
resilience score, with the eﬀect being strongest for resilience scores of
40 or below. Interactions were investigated between the exposures
included in the ﬁnal model for suicidality and study site. None of the
interactions were found to be signiﬁcant at the 5% level.
3.3. Association of MDD and MHS with negative outcomes
Ordinal logistic regression models or logistic regression models
were ﬁtted as appropriate to ﬁnd whether MDD or MHS were
associated with negative functional or behavioural outcomes, adjusting
a priori for study site, sex, age, CD4 cell count and educational level.
Table 5 shows the association of MDD and MHS with the negative
outcomes.
None of the negative outcomes was signiﬁcantly associated with
MHS in this study. Participants with MDD had more than double the
odds of having a greater number of days disrupted compared to those
without MDD. There was some evidence (P=0.071) that participants
with MDD had higher odds than those without MDD of having a
greater number of visits to a Health Unit. Participants with MDD had
over three times the odds of being admitted to a health facility for a
larger number of days than participants without MDD. Participants
with MDD had a signiﬁcantly higher odds than participants without
MDD of having missed a dose of Septrin / Dapsone. The associations of
MDD with the number of risky sexual behaviours, with having engaged
in any risky sexual behaviour and with having engaged in risky sexual
behaviour without using a condom were not statistically signiﬁcant,
although the associated odds ratios were suggestive of a possible
association.
4. Discussion
On the prevalence of the investigated psychiatric disorders, the
burden of major depressive disorder (MDD) in this study was high at
14.0%, with the rate of MDD at the rural site of Masaka ( 19.4%) twice
that seen at the semi-urban site of Entebbe ( 8.0%). The rate of MDD of
8.0% reported at the semi-urban site was very similar to the rate of
Table 3
Results of fitting multiple logistic regression models for factors associated with major
depressive disorder (MDD).
Factor Level Odds Ratio (95%
Conﬁdence Interval)
Likelihood
Ratio P-value
Study Site Entebbe 1 (Reference Level) < 0.0001
Masaka 3.13 (1.83; 5.38)
Age in years Per ten year
increase
0.93 (0.73; 1.20) 0.58
Sex Male 1 (Reference level) 0.11
Female 1.60 (0.88; 2.94)
100 / √(Resilience
score)a
Per unit
increase
1.28 (1.12; 1.45) 0.0003
Stigma Score Per one SD
increase
1.37 (1.08; 1.73) 0.009
Childhood trauma
score
Per one SD
increase
1.25 (1.02; 1.55) 0.036
Negative Coping
Score
Per one SD
increase
1.50 (1.17; 1.92) 0.0038
Negative Life
experiences
score
Per one SD
increase
1.81 (1.46; 2.25) < 0.0001
Note:
a The odds of depression decrease with increasing resilience, but with a diminishing
eﬀect i.e. the eﬀect is most marked for a resilience score below 50.
Table 4
Results of fitting multiple logistic regression models for factors associated with moderate
to high risk of suicidality (MHS).
Factor Level Odds Ratio (95%
Conﬁdence
Interval)
Likelihood
Ratio P-value
Study Site Entebbe 1 (Reference Level) 0.28
Masaka 0.53 (0.17; 1.66)
SES index Per unit
increase
0.86 (0.74; 0.996) 0.040
Employment
status
Any employed 1 (Reference level) 0.007
Unemployed or
retired
4.02 (1.53; 10.58)
200 / (Resilience
score)a
Per unit
increase
1.75 (1.23; 2.49) 0.003
Stigma Score Per one SD
increase
1.67 (1.01; 2.76) 0.045
MDD excluding
suicidality
items
No 1 (Reference Level) 0.0001
Yes 7.55 (2.73; 20.87)
a The odds of moderate to high risk of suicidality decrease with increasing resilience,
but with a diminishing eﬀect i.e. the eﬀect is most marked for a resilience score below 40.
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8.1% that was reported in a previous study in the same district that was
carried out at two government run HIV clinics among a predominantly
late stage HIV clinical disease sample (Kinyanda et al., 2011a). These
results suggest that rates of MDD in early stage HIV clinical disease
may be similar to those in late stage HIV clinical disease.
In this study, the overall prevalence of those who had a ‘moderate to
high risk for suicidality’ (MHS) was 2.8% with the rate of 3.6%
observed in rural Masaka and a rate of 1.9% in semi-urban Entebbe.
Two previous studies undertaken in predominantly late stage HIV
clinical disease samples attending HIV care services at two semi-urban
sites (Entebbe and Mbarara districts) in Uganda reported rates of MHS
of 7.8% (Kinyanda et al., 2012a) and a rate of 8.8% for suicidal ideation
and 3.1% for suicide attempt (Rukundo et al., 2016) which were much
higher than those reported in this study. These results suggest that
early stage HIV clinical disease may be associated with lower rates of
MHS compared to late stage HIV clinical disease. Eighty percent of the
respondents with MHS had comorbid MDD, a previous study under-
taken by this research group among HIV positive patients reported a
signiﬁcant association between suicidality and the psychiatric diag-
noses of post traumatic stress disorder, generalised anxiety disorder
and major depressive disorder but not alcohol dependency disorder
(Kinyanda et al., 2012a). Jia et al. (2012) examining the national
registers in Denmark similarly observed that comorbidity between
HIV/AIDS and psychiatric illness increased the risk of suicide.
The risk factors signiﬁcantly associated with MDD from a multi-
variable analysis were in the three domains of the conceptual frame-
work underlined by the stress-vulnerability model for depression
(Monroe and Simons, 1991), namely: socio-demographics ( study site);
vulnerability/protective factors (childhood trauma, HIV felt stigma,
negative coping scale and low resilience); and stress factors (negative
life experiences score). None of the investigated clinical factors (family
history of mental illness, CD4 counts and WHO clinical sage) nor
neurocognitive impairment were signiﬁcantly associated with MDD in
a multivariable analysis. These ﬁnding are in agreement with previous
research which has documented the following risk factors for MDD in
HIV/AIDS, negative coping style, childhood trauma, low resilience,
stress and stigma (Kinyanda et al., 2012a; Koopman et al., 2000;
Simoni and Ng, 2000; Spies and Seedat, 2014; Judd et al., 2005;
Vyavaharkar et al., 2010). The variable ‘study site’ which was inde-
pendently associated with MDD seems to represent ecological factors.
Possible ecological level factors that would explain the higher rates of
both MDD and MHS observed at the rural site compared to the semi-
urban site include more diﬃcult life conditions including a greater risk
to economic shocks (such as crop failure) in rural areas compared to
urban areas and poorer access to social amenities (such as health care,
transport and schooling) in the rural areas compared to the urban
areas. There is however a need for more studies to investigate the
ecological level factors that are associated with psychiatric problems in
HIV/AIDS in the sub-Saharan African setting.
The risk factors signiﬁcantly associated with MHS at multivariate
analysis were in only two of the domains of the conceptual framework
that was underlined by the stress-vulnerability model of suicidality
(Mann et al., 1999; Wasserman, 2001), namely, socio-demographic
factors (indices of low social economic status- the SES score and
unemployment) and vulnerability/protective factors (depression, HIV
felt stigma and low resilience). These ﬁnding are in agreement with
previous research which has documented the following risk factors for
MHS in HIV/AIDS, low socio-economic status, unemployment, low
resilience, stigma, and depression (Aschan et al., 2013; Qin et al., 2003;
Roya et al., 2007; Schlebusch and Vawda, 2010; Kinyanda et al.,
2012a). In this study none of the investigated stress factors nor clinical
factors were signiﬁcantly associated with MHS at multivariate analysis
unlike in the previous study undertaken by this research group
(Kinyanda et al., 2012a). In the MHS analysis, failure to attain
statistical signiﬁcance for some of the investigated factors could have
been attributed to the low study power which was due to the small
number of study participants (25/899) who met criteria for MHS in
this study.
In this study MDD but not MHS was signiﬁcantly associated with
impaired psychosocial functioning, more utilisation of health services
and non-adherence to Septrin / Dapsone. Neither MDD nor MHS was
associated with high risk sexual behaviour in this study. Previous
studies have reported the association between MDD and psychosocial
impairment in HIV/AIDS (Kinyanda et al., 2011a), increased utilisa-
tion of psychiatric services (McCracken et al., 2006), and non-
adherence to HIV/AIDS treatment (Gonzalez et al., 2011).
In conclusion, the results from this study seem to suggest that early
stage HIV clinical disease is associated with a rate of MDD similar to
that reported in late stage HIV clinical disease but a rate of MHS that is
lower than that reported in late stage HIV clinical disease. Secondly,
MDD but not MHS was associated with risk factors in all the domains
of the conceptual framework (that is underlined by the stress-vulner-
ability model) suggesting that MDD but not MHS in this study is better
ﬁtted to the hypothesized stress-vulnerability model. Lastly, MDD but
not MHS was associated with negative clinical and behavioural out-
comes in this study. The translated standardised clinical assessment
tools used in this study although not taken through a formal validation
process were associated with good indices of internal consistency
suggesting that they were good measures of the stated constructs in
this African socio-cultural context.
On study limitations, this having been a cross-sectional study, the
actual direction of causality between the psychiatric problems and the
investigated risk factors and negative outcomes could not be deter-
mined because some of these relationships are bi-directional, hence the
need for longitudinal studies (Collins et al., 2006). This study did not
include alcohol and substance abuse data which are potential risk
factors of both MDD and suicidality. However, previous work under-
taken by this research group in one of the study districts showed very
low rates (0.7%) of alcohol abuse disorders among persons living with
HIV hence the decision not to include these variables in this study
(Kinyanda et al., 2011a).
Another limitation of this study is that the psychological assessment
Table 5
Association of depression and suicidality with negative outcomes: .
Depression Suicidality
Outcome aaOR (95% CI) LR P-value aaOR (95% CI) LR P-value
Number of days disrupted in the last month 2.19 (1.45; 3.30) 0.0003 1.69 (0.77; 3.68) 0.19
Number of visits to a Health Unit in the last month 1.50 (0.97; 2.32) 0.071 1.55 (0.68; 3.55) 0.31
Number of days admitted to hospital in the last month 3.32 (1.32; 8.36) 0.016 1.83 (0.44; 7.57) 0.42
Number of risky sexual behaviours in the last month 1.60 (0.89; 2.90) 0.13 0.94 (0.29; 3.11) 0.92
Any risky sexual behaviour in the last month 1.48 (0.82; 2.68) 0.20 1.01 (0.31; 3.34) 0.98
Risky sexual behaviour without a condom in the last month 2.44 (0.76; 7.78) 0.13 0.19 (0.015; 2.43) 0.17
Missed Septrin / Dapsone prophylaxis in the last 3 days 1.63 (1.02; 2.61) 0.046 0.45 (0.14; 1.43) 0.15
a Adjusted odds ratio: Adjusted for study site, age, sex, educational level and most recent CD4 count (in the past 6 months).
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instruments being used for the ﬁrst time were not taken through a
formal validation process but were however taken through a process of
forward and backward translation and were required to meet a
minimum threshold on the reliability index before they could be
employed in further analysis in this study. On limitations associated
with the modelling strategy used in this study, in order to reduce the
shortcomings of automatic variable selection we followed a strategy in
which the variables were added to the model in groups, starting with
the group of variables deemed to be most distal to the outcome. We
also restricted the pool of potential explanatory variables using prior
knowledge and scientiﬁc plausibility.
On clinical relevance of this study, since this study has shown that
the prevalence of MDD and MHS in early stage HIV clinical disease is
considerable, there is need to integrate mental health care in all HIV
care programmes targeting persons in early stage HIV clinical disease.
Secondly, since the risk factors of MDD and MHS observed in this
socio-cultural setting include social, psychological and socio-economic
factors, there is need for a multifaceted approach to mental health
prevention in HIV/AIDS in this socio-cultural context. Thirdly, since
MDD in this study has been shown to negatively impact the HIV
outcomes of psychosocial functioning, adherence and service utilisa-
tion, programmes targeting these HIV outcomes should include screen-
ing and management of MDD.
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Appendix A. Data collection tools for this study
Instrument used Description Questions or cate-
gories (examples)
Cronbach's
alpha
Remarks Reference
Group 1 factors
(Socio-demo-
graphic factors)
study site, sex, age,
marital status,
highest educational
attainment, re-
ligion, employment
status, Socio-eco-
nomic index (SEI)
SEI was constructed
from commonly avail-
able household items
in a typical Ugandan
households, has pre-
viously been used by
this group (Kinyanda
et al., 2011c)
Examples of questions in
the SEI: does your
household have elec-
tricity?
Has previously
been used by
this study group.
Kinyanda
et al.
(2011a),
(2012a)
Response:
Yes/no
Index created by total-
ling up all positive
items
Group 2 A fac-
tors
CD4 counts CD4 count taken in
the last 6 months
WHO clinical stage
for HIV/AIDS
WHO Clinical
Staging criteria
Respondents classiﬁed
as Stage I to IV based on
the presence/absence a
combination of 17 HIV
associated clinical symp-
toms
World Health
Organization
(2007)
HIV associated
Neurocognitive
impairment
International HIV
Dementia scale
3-item questi. assesses
motor, psychomotor
and memory impair-
ment
Memory -Ask the patient
to recall the four words.
Sacktor et al.
(2005)
Maximum total score is
16
Body weight (Kg)
Degree of disability Sheehan Disability
Scale (SDS)
Assesses degree of im-
pairment in 3 domains
work/school, social life
and home life or family
responsibilities. are
impaired by his or her
symptoms on a 10
point visual analog
scale.
Use a 10 point visual
analog scale to assess
each of the 3 domains
Sheehan
(2000)
Childhood trauma Childhood Trauma
Questionnaire
Short Form CTQ-SF
28-item questionnaire
on traumatic events in
childhood
Selected examples: 0.88 Employed for
the ﬁrst time.
Bernstein
and Fink
(1998)
Did your mother die?
Reverse scored
items: 2, 5, 7,
10, 13, 16, 19,
22, 28.
Response: 1= Yes
2= No
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Social support Multidimensional
Scale of Perceived
Social Support
MSPSS
12-item questi. on
perceptions of support
received
Does your family sup-
port you?
0.85 Employed for
ﬁrst time.
Dahlem et al.
(1991)
7-point Likert scale:
very strongly disagree /
strongly disagree / etc.
HIV Felt Stigma Brief HIV Stigma
Scale
10-item questi. on ex-
periences, feelings, and
opinions as to how
PLWHA are treated
I have been hurt by how
people reacted to learn-
ing I have HIV.
0.77 Employed for
ﬁrst time.
Wright et al.
(2007)
4-point Likert scale:
strongly disagree /dis-
agree/ agree/etc.
Negative Coping
style
Carver Brief COPE 28-item questi. on style
of coping with stress
I've been turning to
work or other activities
to take my mind oﬀ
things.
0.69 Employed for
ﬁrst time.
Carver
(1997)
Reverse scored
items: 1, 2, 5,
7, 10, 12, 14,
15, 17, 18, 19,
20, 22, 23, 24,
25, 27, 28.
4-point Likert scale:
I haven't been doing
this at all/ I've been
doing this a little bit /
I've been doing this a
medium amount/ etc.
Resilience Connor–Davidson
Resilience Scale
CDRISC
25-item questi. on
stress coping ability
I am able to adapt when
changes occur.
0.93 Employed for
ﬁrst time.
Connor and
Davidson
(2003)5-Likert scale
not true at all/ rarely
true/ sometimes true/
etc.
Family history of
mental disorder
1-item Have any members of
your family ever been
diagnosed with a psy-
chiatric disorder?
Has previously
been used by
this study group.
Kinyanda
et al.
(2011a),
(2012a)
Responses: yes/no
When did you know
your HIV status?
One item question Closed question When did you know
your HIV status?
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
Kinyanda
et al.
(2011a),
(2012a)
Responses: 1=less the
3 months ago; 2= be-
tween 3 and 6 months
ago;
3= between 6 and 12
months ago;
4=more than 12
months ago
Group 2B factors
Negative life events Modiﬁed Adverse
life events module
of the European
Parasuicide
Interview schedule
EPSIS
27-item questi. on ad-
verse life events ex-
perienced in the last 6-
months with related to
parents, sibling, chil-
dren and self.
Did your father die in
the last 6 months?
Previously adap-
ted to the
Ugandan socio-
cultural context
and used in HIV
research [6–8].
Kerkhof et al.
(1989);
Kinyanda
et al. (2005)
Response:
yes/no
Index created by total-
ling up positive items
Stress Derived from items
of the Modiﬁed ad-
verse life events
module of the
EPSIS
27-items based on an
objective measure of
stress
Diﬀerent life events were
weighted on an objective
assessment of stress e.g.
death of spouse or child
in the last 6 months was
given a stress score of 5;
sickness of important
others a stress score of 2,
etc.
A previous ver-
sion of this scale
has been used in
the HIV situa-
tion of Uganda
by authors.
Kinyanda
et al.
(2011a),
(2012a)
Stress Index was cre-
ated by totalling up all
the scores.
Food insecurity One item question Closed question In the last month, did
you or your family have
enough food?
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
Kinyanda
et al.
(2011a),
(2012a)Response yes/no
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Group C Other
psychiatric
Outcomes
Severity of depres-
sive symptoms
Assessed using the
Centre for
Epidemiological
Studies-Depression
questionnaire
(CES-D)
Standardised screening
questionnaire
For the past two Radloﬀ
(1997)weeks, I did not feel
like eating; my appe-
tite was poor.
4-point Likert scale:
rarely or none of the
time/some or a little of
the time/ occasionally
or moderate amount of
the time/ etc
Group 3
Negative clinical
and beha-
vioural out-
comes
Assessed by asking the
question, ‘in the last
month, on how many
days were your normal
activities disrupted
through illness?
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
Kinyanda
et al. (2011a)
Psychosocial
functioning
Utilisation of health
services
Assessed by asking the
questions, ‘how many
times did you visit the
health unit in the last
month?’ and ‘for how
many days were you
admitted to hospital in
the last month?’
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
Kinyanda
et al. (2011a)
Adherence to medi-
cations (septrin/
dapsone)
Assessed by asking the
question, ‘for those on
septrin/dapsone: have
you on any day missed
taking septrin/dapsone
in the last 3 days?’
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
Kinyanda
et al. (2011a)
High risk sexual
behaviour
Assessed for high
risk sexual beha-
viours that have
been associated
with HIV transmis-
sion in the Ugandan
cultural context.
Assessed high risk sexual
behavioural practices
such as: ‘in the last
month, have you had sex
with anyone other than
your regular partner?’
Previously used
in the HIV si-
tuation of
Uganda by au-
thors.
MOH,
Uganda,
2006;
Uganda AIDS
Commission
(2005);
Kinyanda
et al. (2012b)
Among those who
practiced high risk
sexual behaviours ‘do
you always use con-
doms?’
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